Royal Bank of Canada’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,200
| Closed | -$24K | – | 7785 |
|
|
2022
Q4 | $24K | Sell |
1,200
-33
| -3% | -$506 | ﹤0.01% | 6243 |
|
|
2022
Q3 | $13K | Sell |
1,233
-167
| -12% | -$1.89K | ﹤0.01% | 6324 |
|
|
2022
Q2 | $17K | Hold |
1,400
| – | – | ﹤0.01% | 6190 |
|
|
2022
Q1 | $30K | Buy |
1,400
+200
| +17% | +$5.3K | ﹤0.01% | 6389 |
|
|
2021
Q4 | $40K | Hold |
1,200
| – | – | ﹤0.01% | 6505 |
|
|
2021
Q3 | $31K | Hold |
1,200
| – | – | ﹤0.01% | 6458 |
|
|
2021
Q2 | $16K | Hold |
1,200
| – | – | ﹤0.01% | 6692 |
|
|
2021
Q1 | $13K | Hold |
1,200
| – | – | ﹤0.01% | 6701 |
|
|
2020
Q4 | $10K | Sell |
1,200
-80
| -6% | -$629 | ﹤0.01% | 6396 |
|
|
2020
Q3 | $10K | Buy |
1,280
+3
| +0.2% | +$27 | ﹤0.01% | 5933 |
|
|
2020
Q2 | $12K | Buy |
1,277
+18
| +1% | +$187 | ﹤0.01% | 5781 |
|
|
2020
Q1 | $12K | Buy |
1,259
+59
| +5% | +$706 | ﹤0.01% | 5776 |
|
|
2019
Q4 | $17K | Sell |
1,200
-106
| -8% | -$1.54K | ﹤0.01% | 5933 |
|
|
2019
Q3 | $20K | Buy |
1,306
+106
| +9% | +$1.48K | ﹤0.01% | 5506 |
|
|
2019
Q2 | $16K | Buy |
+1,200
| New | +$14.5K | ﹤0.01% | 5826 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | – | – | 7284 |
|
|
2018
Q3 | $0 | Sell |
5
-3,783
| -100% | -$65.5K | ﹤0.01% | 7065 |
|
|
2018
Q2 | $55K | Buy |
+3,788
| New | +$66.6K | ﹤0.01% | 5120 |
|
|
2018
Q1 | – | Sell |
-145
| Closed | -$3K | – | 6951 |
|
|
2017
Q4 | $3K | Sell |
145
-55
| -28% | -$1.76K | ﹤0.01% | 6225 |
|
|
2017
Q3 | $7K | Buy |
+200
| New | +$7.46K | ﹤0.01% | 6368 |
|
Royal Bank of Canada's OPNT Position: Q1 2023 in Review
Royal Bank of Canada sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 1,200 shares — an estimated $24K sold.
Royal Bank of Canada first reported a position in OPNT in Q3 2017 and held it in 19 quarters. The position peaked at $55K in Q2 2018. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.
- Royal Bank of Canada reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Royal Bank of Canada sold 1,200 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $24K.
- Royal Bank of Canada first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 19 quarters.
- Royal Bank of Canada's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $55K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.
Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.